This protein catalyzes the oxygen-dependent 5-hydroxyuridine (ho5U) modification at position 34 in tRNAs.
KEGG: bca:BCE_1961
BCE_1961 belongs to the UPF0176 protein family in Bacillus cereus and likely shares structural similarities with other proteins in this family. Like BCE33L1694, it contains approximately 316-319 amino acids with characteristic N-terminal SH3_3 domains (PF08239) involved in protein-protein interactions and a C-terminal cell wall binding domain known as 3D domain (PF06725) . The protein likely contains a signal peptide sequence of approximately 24 residues at the N-terminus that is cleaved in the mature protein . The predicted molecular mass is around 33-34 kDa with an isoelectric point of approximately 8.9, similar to related UPF0176 proteins .
The shelf life of recombinant BCE_1961 depends on several factors including storage state, buffer ingredients, and storage temperature. For optimal stability, the following guidelines are recommended:
| Form | Storage Temperature | Shelf Life |
|---|---|---|
| Liquid | -20°C/-80°C | Approximately 6 months |
| Lyophilized | -20°C/-80°C | Approximately 12 months |
Repeated freezing and thawing should be avoided as it may compromise protein integrity. Working aliquots can be stored at 4°C for up to one week to minimize freeze-thaw cycles . For long-term storage, addition of 5-50% glycerol (with 50% being typical) as a cryoprotectant is recommended when storing in liquid form .
For optimal reconstitution of lyophilized BCE_1961, the following procedure is recommended:
Briefly centrifuge the vial prior to opening to bring contents to the bottom
Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Add glycerol to a final concentration of 5-50% (50% is standard for most applications)
Aliquot the reconstituted protein to minimize freeze-thaw cycles
This protocol helps maintain protein stability and activity while minimizing degradation that could affect experimental outcomes.
BCE_1961 can be successfully expressed in E. coli expression systems, similar to other UPF0176 family proteins . When designing expression constructs, researchers should consider:
Including the full-length sequence (approximately 319 amino acids)
Choosing appropriate affinity tags that won't interfere with protein function
Optimizing codon usage for E. coli if necessary
Selecting expression vectors with appropriate promoters for controlled expression
The tag type should be determined based on the specific experimental requirements, as it may influence protein folding, solubility, and downstream applications .
Based on studies of similar UPF0176 family proteins like EntD, BCE_1961 likely plays a significant role in bacterial growth and metabolism. Disruption of similar genes results in significant growth impairment with approximately 50% reduction in growth rate and altered metabolic profiles . The following metabolic pathways may be affected:
Glucose uptake and glycolysis - disruption of similar genes decreases glycolytic rate
Pyruvate metabolism - affected through altered pyruvate dehydrogenase complex functionality
Acetate overflow - typically reduced by approximately 50% in mutant strains
TCA cycle interconnection - disrupted due to changes in acetyl-CoA metabolism
These effects appear to be oxygen-independent, suggesting BCE_1961 impacts core metabolic functions rather than specific aerobic or anaerobic pathways .
Disruption of UPF0176 family proteins like EntD leads to extensive proteome remodeling, affecting approximately 300 proteins across multiple functional categories. Based on proteomic analysis of similar proteins, the following patterns may be observed with BCE_1961 disruption:
| Functional Category | Upregulated Proteins | Downregulated Proteins | Key Affected Pathways |
|---|---|---|---|
| Metabolism | Multiple enzymes involved in alternative carbon utilization | Glycolytic enzymes, PDC complex components | Central carbon metabolism |
| Cell Structure | Cell wall synthesis proteins, autolysis-related proteins | Flagella components | Cell morphology, motility |
| Stress Response | Oxidative stress response proteins | Virulence factors | Stress adaptation, pathogenicity |
The extensive changes suggest BCE_1961 may function as a regulatory protein affecting multiple cellular processes either directly or indirectly through protein-protein interactions facilitated by its SH3_3 domains .
BCE_1961, like other UPF0176 family proteins, may play a significant role in B. cereus virulence through multiple mechanisms:
Regulation of toxin production - disruption of similar genes reduces expression of virulence factors
Influence on cell morphology - affecting bacterial cell wall structure and integrity
Impact on motility - through downregulation of flagellar proteins
Metabolic adaptation - allowing optimal growth in host environments
Stress response modulation - affecting bacterial survival under host-imposed stress conditions
Cytotoxicity assays with mutant strains lacking similar proteins show reduced pathogenic potential, suggesting BCE_1961 may be a potential target for antimicrobial development .
BCE_1961 likely shares significant sequence similarity with other Ent family proteins (EntA, EntB, EntC, and EntD), with predicted sequence identity of approximately 60-70% . These proteins contain similar domain architecture with N-terminal SH3_3 domains and C-terminal cell wall binding domains. Functional analysis suggests they may have partially overlapping but non-redundant functions, as disruption of individual genes produces distinct phenotypes . Comparative analysis of expression patterns shows these genes are differentially regulated, with highest expression typically occurring during early exponential growth phase .
For precise functional characterization of BCE_1961, gene disruption or deletion mutants can be constructed using the following methodology:
PCR amplification of the genomic region containing BCE_1961 with appropriate restriction sites
Cloning into a suitable vector (e.g., pCRXL-TOPO)
Insertion of an antibiotic resistance cassette (e.g., spectinomycin resistance) at an appropriate restriction site within the gene
Subcloning into a temperature-sensitive shuttle vector like pMAD
Introduction into B. cereus by electroporation
Selection for double crossover events to replace the wild-type allele
A comprehensive assessment of BCE_1961's physiological impact should include:
Growth curve analysis in various media and conditions (aerobic and anaerobic)
Measurement of key metabolites (e.g., acetate, glucose consumption) using HPLC or enzymatic assays
Cellular morphology examination using:
Light microscopy for basic morphological changes
Transmission electron microscopy (TEM) for ultrastructural analysis
Negative staining for flagella visualization
Motility assays using semi-solid agar plates
Autolysis assessment by monitoring OD600 decrease in buffer over time (72 hours is recommended)
Statistical comparison between wild-type and mutant strains should be performed using Student's t-test or ANOVA depending on the experimental design.
To elucidate BCE_1961's interaction network, the following approaches are recommended:
Pull-down assays using recombinant tagged BCE_1961 as bait
Bacterial two-hybrid systems to identify direct protein interactions
Co-immunoprecipitation followed by mass spectrometry (MS/MS) analysis
Chemical cross-linking coupled with MS to capture transient interactions
Label-free proteomic comparison between wild-type and BCE_1961 mutant strains to identify regulated proteins
For MS-based proteomics, a workflow similar to that used for EntD characterization is recommended, which involved:
Sample preparation from multiple growth phases
LC-MS/MS analysis on biological triplicates
Identification of proteins with significantly altered abundance (p < 0.05)
This approach identified approximately 300 regulated proteins in related studies, providing a comprehensive view of the protein's functional impact.
To understand BCE_1961 transcriptional regulation, researchers should:
Determine the transcriptional start site using 5' RACE or similar techniques
Identify promoter elements upstream of the transcriptional start site
Analyze expression levels across different growth phases using reverse transcription PCR or qRT-PCR
Investigate potential regulators using:
Electrophoretic mobility shift assays (EMSA) to detect protein-DNA interactions
Reporter gene fusions to monitor promoter activity
ChIP-seq to identify transcription factor binding sites genome-wide
For BCE_1961, similar proteins show highest expression during early exponential growth phase, with a putative housekeeping σA type -10 sequence (5′-TATAAT-3′) and a σD type -35 sequence (5′-CTAAA-3′) in their promoter regions . Terminator structures may also be present, suggesting transcription as a single unit rather than as part of an operon.
Proteomic analysis of BCE_1961 function should employ a rigorous statistical approach:
Perform experiments with at least three biological replicates
Use label-free quantification based on spectral counts or intensity
Apply appropriate statistical tests (p < 0.05 threshold is standard)
Categorize regulated proteins into functional groups
Apply pathway enrichment analysis to identify affected biological processes
In studies of similar proteins, approximately 40,000-50,000 MS/MS spectra yielded identification of 600-700 proteins, with approximately 300 showing significant abundance changes between wild-type and mutant strains . Researchers should expect similar coverage when studying BCE_1961.
Wild-type strain cultured under identical conditions
Complemented mutant strain (restoring the gene) to confirm phenotype specificity
Empty vector controls for complementation studies
Verification of gene disruption/deletion by:
RT-PCR to confirm absence of transcript
Proteomic analysis to confirm absence of protein
PCR verification of genomic modification
Growth phase standardization (sampling at equivalent growth phase rather than time points)
Particularly important is the verification that any observed phenotypes are specifically due to BCE_1961 disruption rather than polar effects on adjacent genes .
BCE_1961 research offers several avenues for advancing understanding of B. cereus pathogenicity:
Identification of virulence regulation networks - BCE_1961 disruption affects numerous proteins involved in pathogenicity
Novel therapeutic target development - proteins essential for virulence represent potential antimicrobial targets
Diagnostic marker identification - specific antibodies against BCE_1961 could aid in B. cereus detection
Strain characterization - BCE_1961 sequence variations may correlate with strain virulence potential
Host-pathogen interaction studies - understanding how BCE_1961 influences bacterial adaptation to host environments
The extensive proteome remodeling observed with disruption of similar proteins suggests BCE_1961 may be a master regulator of pathogenicity-associated functions, making it particularly valuable for understanding B. cereus virulence mechanisms .
Complementation studies for BCE_1961 present several challenges that researchers should anticipate:
Dosage effects - multicopy plasmids may lead to overexpression that fails to restore wild-type phenotypes
Regulatory context - insertion at non-native locations may alter gene regulation
Polar effects - disruption may affect adjacent genes, complicating interpretation
Post-translational modifications - complementation may restore protein but not modifications
Timing of expression - non-native promoters may alter expression timing during growth phases
Researchers should verify complementation by measuring BCE_1961 expression levels through RT-PCR and protein abundance through MS/MS, comparing to wild-type levels . Alternative complementation strategies using single-copy integration at neutral sites may be necessary if multicopy plasmids fail to restore wild-type phenotypes.
A comprehensive BCE_1961 research project should address:
Multiple aspects of bacterial physiology (growth, metabolism, morphology, motility)
Both cellular proteome and exoproteome changes
Temporal dynamics (multiple growth phases)
Complementary approaches (genetics, proteomics, microscopy, biochemistry)
Functional validation through multiple independent methods
Comparative analysis with other UPF0176 family proteins